Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hydatidiform Mole 2Gestational Trophoblastic Disease 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16camrelizumab 15Radiation 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Vacuum Curettage × Clear all
NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT01630954 2016-03-23

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

Nilratan Sircar Medical College

Phase 4 Unknown
120 enrolled

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡